A critical platform technology to synthesise drug compounds at scale – and onshore production in Australia – has been successfully demonstrated in a collaboration between Melbourne company Boron Molecular, and innovation and technology development specialists, DMTC Limited, with support from Australia’s national science agency, CSIRO. (more…)
Posted by Harry Baxter on July 25th, 2024 Tagged: collaboration, DMTC, Health Security, industry, MCM, research
A collaboration between Melbourne chemical company Boron Molecular and DMTC Limited is testing a new system capable of synthesising drugs at scale, quickly and continuously. (more…)
Posted by Harry Baxter on March 31st, 2021 Tagged: collaboration, CSIRO, defence technology, DMTC, MCM
Australian industry has a vital role to play in the COVID-19 response, with regard to both developing novel solutions and consolidating supply chain strength in the face of this and potential future pandemic threats. Australian industry has a critical role in ensuring supply of essential therapeutics and active pharmaceutical ingredients for vaccine and drug development. (more…)
Posted by Harry Baxter on October 7th, 2020 Tagged: collaboration, Countermeasures, DMTC, DST, innovation, MCM
The challenge to develop a safe, effective and low-cost universal malaria vaccine is being tackled by a DMTC collaboration with James Cook University’s Australian Institute of Tropical Health Medicine (AITHM), Townsville Hospital, Glycosyn and Pfizer Hospira. (more…)
Posted by Harry Baxter on September 4th, 2020 Tagged: collaboration, DMTC, innovation, MCM, technology